Conference abstractPublished 16 Mar 2015
Epigenetic disruption of cell signaling in human cancer pathogenesis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Carcinogenesis involves multiple genetic and epigenetic alterations of cancer genes, including the epigenetic disruption of many tumor suppressor genes (TSG) by promoter CpG methylation. These epigenetic abnormalities provide us with useful epigenetic biomarkers for novel TSG identification as well as cancer diagnosis. Through integrative cancer epigenetics/ epigenomics, we have identified a series of methylated cancer genes, including various nuclear proteins and regulatory genes involved in cell signaling regulation. These candidate genes could induce tumor cell apoptosis and suppress tumor cell growth, are thus functional TSGs. Epigenetic silencing of these TSGs leads to the disrupting of normal cell signaling including Ras, WNT/b-catenin and nuclear signaling, which further facilitates the de-regulation of cell cycle, apoptosis, cell stemness and metastasis. These TSGs are frequently methylated and downregulated in aero- and digestive tumors in a tumor-specific manner, thus could serve as non-invasive epigenetic biomarkers for early tumor detection and prognosis prediction, as well as therapeutic targeting.
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Gastrointestinal & Digestive System
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Qian Tao”